Literature DB >> 19302046

Cell-mediated immune responses in tuberculosis.

Andrea M Cooper1.   

Abstract

Tuberculosis is primarily a disease of the lung, and dissemination of the disease depends on productive infection of this critical organ. Upon aerosol infection with Mycobacterium tuberculosis (Mtb), the acquired cellular immune response is slow to be induced and to be expressed within the lung. This slowness allows infection to become well established; thus, the acquired response is expressed in an inflammatory site that has been initiated and modulated by the bacterium. Mtb has a variety of surface molecules that interact with the innate response, and this interaction along with the autoregulation of the immune response by several mechanisms results in less-than-optimal control of bacterial growth. To improve current vaccine strategies, we must understand the factors that mediate induction, expression, and regulation of the immune response in the lung. We must also determine how to induce both known and novel immunoprotective responses without inducing immunopathologic consequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302046      PMCID: PMC4298253          DOI: 10.1146/annurev.immunol.021908.132703

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  173 in total

1.  CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis.

Authors:  Bernadette M Saunders; Anthony A Frank; Ian M Orme; Andrea M Cooper
Journal:  Cell Immunol       Date:  2002 Mar-Apr       Impact factor: 4.868

2.  Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish.

Authors:  Annemarie H Meijer; Astrid M van der Sar; Cristiana Cunha; Gerda E M Lamers; Mary A Laplante; Hiroshi Kikuta; Wilbert Bitter; Thomas S Becker; Herman P Spaink
Journal:  Dev Comp Immunol       Date:  2007-05-22       Impact factor: 3.636

3.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production.

Authors:  Caroline Demangel; Patrick Bertolino; Warwick J Britton
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

5.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

6.  Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis.

Authors:  Kamlesh Bhatt; Somia Perdow Hickman; Padmini Salgame
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis.

Authors:  A M Cooper; J E Callahan; M Keen; J T Belisle; I M Orme
Journal:  Tuber Lung Dis       Date:  1997

8.  Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein.

Authors:  Scott A Fulton; Scott M Reba; Rish K Pai; Meghan Pennini; Martha Torres; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.

Authors:  Adrian R Martineau; Katalin A Wilkinson; Sandra M Newton; R Andres Floto; Anthony W Norman; Keira Skolimowska; Robert N Davidson; Ole E Sørensen; Beate Kampmann; Christopher J Griffiths; Robert J Wilkinson
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Lyudmila A Lyakh; Giovanna Batoni; Semih Esin; Robin T Winkler-Pickett; Maria Rita Consolaro; Mario De Marchi; Daniela Giachino; Angela Robbiano; Marco Astegiano; Angela Sambataro; Robert A Kastelein; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

View more
  457 in total

1.  BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis.

Authors:  Jin-Cheng Zeng; Dong-Zi Lin; Lai-Long Yi; Gan-Bin Liu; Hui Zhang; Wan-Dang Wang; Jun-Ai Zhang; Xian-Jing Wu; Wen-Yu Xiang; Bin Kong; Zheng W Chen; Cong-Yi Wang; Jun-Fa Xu
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

3.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

4.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

5.  Editorial: Be careful what you ask for: is the presence of IL-17 indicative of immunity?

Authors:  Andrea M Cooper
Journal:  J Leukoc Biol       Date:  2010-08       Impact factor: 4.962

6.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

Review 7.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

8.  No significant impact of IFN-γ pathway gene variants on tuberculosis susceptibility in a West African population.

Authors:  Christian G Meyer; Christopher D Intemann; Birgit Förster; Ellis Owusu-Dabo; Andre Franke; Rolf D Horstmann; Thorsten Thye
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

9.  Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Authors:  M Jeyanathan; N Thanthrige-Don; S Afkhami; R Lai; D Damjanovic; A Zganiacz; X Feng; X-D Yao; K L Rosenthal; M Fe Medina; J Gauldie; H C Ertl; Z Xing
Journal:  Mucosal Immunol       Date:  2015-04-15       Impact factor: 7.313

10.  Immunology of tuberculosis.

Authors:  Qing Zhang; Isamu Sugawara
Journal:  World J Exp Med       Date:  2012-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.